25 oct
|
AstraZeneca
|
Canarias
25 oct
AstraZeneca
Canarias
AstraZeneca Rare Disease is seeking a Director to lead general value, access, and pricing strategies for NMOSD, with a strong focus on Neurology indications and lifecycle management. You will shape payer strategies across EU markets and collaborate with cross-functional teams to enable rapid patient access. The role requires deep HTA/payer expertise, strategic thinking, and the ability to drive evidence generation plans, market access readiness, and local P&R; submissions in a high-visibility #J-18808-Ljbffr
📌 Global NMOSD Access (Canarias)
🏢 AstraZeneca
📍 Canarias